Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Advancing knowledge in the field of heart failure management
The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.
The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.
Sodium–glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: Analyses of short‐term efficacy and safety
Author(s):
Frederick M. Lang,
Sergio Teruya,
Ariel Weinsaft,
Margaret Cuomo,
Alfonsina Mirabal Santos,
Ani Nalbandian,
Dimitrios Bampatsias,
Mathew S. Maurer
14 Mar 2024
Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension
Author(s):
Christian Gerges,
Karl Vollmers,
Nika Skoro‐Sajer,
Varius Dannenberg,
Valerie Hartig,
Marc R. Pritzker,
John Scandurra,
E. Kenneth Weir,
Irene M. Lang
15 Mar 2024
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER
Author(s):
Alexander Peikert,
Muthiah Vaduganathan,
Brian L. Claggett,
Ian J. Kulac,
Alberto Foà,
Akshay S. Desai,
Pardeep S. Jhund,
Jaclyn Carberry,
Carolyn S.P. Lam,
Mikhail N. Kosiborod,
Silvio E. Inzucchi,
Felipe A. Martinez,
Rudolf A. de Boer,
Adrian F. Hernandez,
Sanjiv J. Shah,
Lars Køber,
Piotr Ponikowski,
Marc S. Sabatine,
Magnus Petersson,
Anna Maria Langkilde,
John J.V. McMurray,
Scott D. Solomon
12 Mar 2024
Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction
Author(s):
Nathanael Wood,
Sam Straw,
Chew W. Cheng,
Yu Hirata,
Marcelo G. Pereira,
Harrison Gallagher,
Stuart Egginton,
Wataru Ogawa,
Stephen B. Wheatcroft,
Klaus K. Witte,
Lee D. Roberts,
T. Scott Bowen
Our mission: To reduce the burden of cardiovascular disease.